CN Patent

CN103965180B — 苯磺酰胺噁唑和噻唑激酶抑制剂

Assigned to Beijing Ao He Research Institute Co Ltd · Expires 2016-09-07 · 10y expired

What this patent protects

本发明属于医药技术领域，具体涉及通式(Ⅰ)所示的苯磺酰胺噁唑和噻唑激酶抑制剂、其药学上可接受的盐或其立体异构体，其中环A、R 1 、R 2 、R 3 、X、m、n和p如说明书中所定义。本发明还涉及这些化合物的制备方法，含有这些化合物的药物制剂和药物组合物，以及该化合物、其药学上可接受的盐或其立体异构体在制备治疗和/或预防由b‑RAF突变引起的癌症相关或非癌症相关疾病的药物中的应用。

USPTO Abstract

本发明属于医药技术领域，具体涉及通式(Ⅰ)所示的苯磺酰胺噁唑和噻唑激酶抑制剂、其药学上可接受的盐或其立体异构体，其中环A、R 1 、R 2 、R 3 、X、m、n和p如说明书中所定义。本发明还涉及这些化合物的制备方法，含有这些化合物的药物制剂和药物组合物，以及该化合物、其药学上可接受的盐或其立体异构体在制备治疗和/或预防由b‑RAF突变引起的癌症相关或非癌症相关疾病的药物中的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN103965180B
Jurisdiction
CN
Classification
—
Expires
2016-09-07
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Ao He Research Institute Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.